|
|
Article: Antacids to see steady growth. (antacid drugs' market share)
- Article from:
- Chain Drug Review
- Article date:
- August 16, 1993
CopyrightCOPYRIGHT 1993 Racher Press, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NEW YORK--For manufacturers and retailers of antacids, bad times can mean good profits.
"So far in the 1990s we've seen recession, the threat of war, serious racial conflicts, labor strife, homelessness and corporate bankruptcies on a huge scale," says David Weiss, president of Packaged Facts Inc., a New York-based research firm. "Facing up to these problems is very stressful, and there aren't any quick fixes in sight. As America keeps bubbling, so will its stomachs, and so will the antacid category."
A few years ago sales were expected to top $952 million in 1993, with growth of 9% to 10% for each of the next two years. Those predictions were based on the ...